The oral chelator deferasirox--a new perspective for patients with iron overload.
Fischer
Roland
R
Children's Hospital and Research Center, Oakland, CA, USA. fischer@uke.uni-hamburg.de
D001565:Benzoates / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077588:Deferasirox; D006207:Half-Life; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy*; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox